TY  - JOUR
T1  - Ciprofloxacin is not a better choice in the patients with diabetes suffering urinary tract infection
AU  - Ugur, Kader
AU  - Bal, İsa Ahmet
AU  - Tartar, Ayse Sagmak
AU  - Gozel, Nevzat
AU  - Orhan, Bedrettin
AU  - Donder, Emir
AU  - Ozercan, Abdullah Mubin
PY  - 2019
DA  - March
DO  - 10.5798/dicletip.474694
JF  - Dicle Medical Journal
JO  - diclemedj
PB  - Dicle University
WT  - DergiPark
SN  - 1300-2945
SP  - 65
EP  - 72
VL  - 46
IS  - 1
LA  - tr
AB  - Objective:The aim of this study is to determine antibacterial susceptibilities ofGram-negative bacteria isolated from diabetic and non-diabetic patients asinfectious agents of community-acquired urinary tract infections (UTI) and tocompare their rates of resistance to the antibiotics frequently used inempirical treatment. Methods:Ninety-six diabetic and sixty-eight non-diabetic (total n=164) patients’ datawere evaluated retrospectively who diagnosed as community-acquired urinarysystem infection and consulted to outpatient clinics of Department ofEndocrinology and Infectious Diseases of Firat University School of Medicinebetween January 1st , 2014 and December 31st, 2014 whose urine culturesdemonstrated Gram-negative bacteria were included in the study. Antibioticsusceptibilities of the isolated bacteria were determined using Vitek 2automated system and the results were evaluated as sensitive and resistant.Results: Inboth diabetic and non-diabetic patient groups, most frequently Escherichia coli(88.5% in diabetic and 85.3% in non-diabetic groups) were isolated. In thediabetic group, microorganisms mostly demonstrated the highest rates ofresistance against ampicillin, cephalosporins, ciprofloxacin,amoxicillin-clavulanic acid and in the non-diabetic group ampicillin,amoxicillin-clavulanic acid, cefuroxime and trimethoprim-sulfamethoxazole.Conclusion:Resistance to ciprofloxacin was at a significantly higher rate in the diabeticgroup. In diabetic patients, it will be more appropriate to give antibiotherapyin urinary system infections based on the antibacterial susceptibility testresults.
KW  - Diabetes mellitus
KW  - urinary tract infection
CR  - 1. International Diabetes Federation. Diabetes Atlas. 6th edition, update 2014. http://www.idf.org/diabetes atlas
CR  - 2. Simkhada R. Urinary tract infection and antibiotic sensitivity pattern among diabetics. Nepal Med Coll J. 2013; 15 :1-4.
CR  - 3. Yu S, Fu AZ, Qiu Y, et al. Disease burden of urinary tract infections among type 2 diabetes mellitus patients in the US. J Diabetes Complications 2014; 28 :621–6.
CR  - 4. Wang MC, Tseng CC, Wu AB, et al. Bacterial characteristics and glycemic control in diabetic patients with Escherichia coli urinary tract infection. J Microbiol Immunol Infect 2013; 46 :24-9.
CR  - 5. Sewify M, Nair S, Warsame S, et al. Prevalence of Urinary Tract Infection and Antimicrobial Susceptibility among Diabetic Patients with Controlled and Uncontrolled Glycemia in Kuwait. J Diabetes Res. 2016; 6573215.
CR  - 6. Rawat V, Singhai M, Kumar A, et al. Bacteriological and resistance profile in isolates from diabetic patients. N Am J Med Sci. 2012; 4 :563-8.
CR  - 7. Nitzan O, Elias M, Chazan B, et al. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes 2015; 8: 129-36.
CR  - 8. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2015; 38: 1-93.
CR  - 9. Catry B, Latour K, Bruyndonckx R, et al. Characteristics of the antibiotic regimen that affect antimicrobial resistance in urinary pathogens. Antimicrob Resist Infect Control. 2018; 7: 76.
CR  - 10. Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO.SENS study revisited. Int J Antimicrob Agents 2012; 39: 45-51.
CR  - 11. Tsakiridou E, Makris D, Chatzipantazi V, et al. Diabetes and hemoglobin a1c as risk factors for nosocomial infections in critically ill patients. Crit Care Res Pract. 2013: 279479.
CR  - 12. Aswani SM, Chandrashekar UK, Shivashankara KN et al. Clinical profile of urinary tract infections in diabetics and non-diabetics. Australasian Medical Journal 2014; 7: 29-34.
CR  - 13. Fünfstück R, Nicolle LE, Hanefeld M, et al. Urinary tract infection in patients with diabetes mellitus. Clin Nephrol 2012; 77 :40-8.
CR  - 14. Geerlings S, Fonseca V, Castro-Diaz D, et al. Genital and urinary tract infections in diabetes: impact of pharmacologically-induced glucosuria. Diabetes Res Clin Pract. 2014; 103 :373-81.
CR  - 15. Hirji I, Guo Z, Anderrson S.W, et al. Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database 2012; 26: 513-6.
CR  - 16. Hammar N, Farahmand B, Gran M, et al. Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials. Pharmacoepidemiol Drug Saf 2010; 19: 1287-92.
CR  - 17. Akhtar MS, Mohsin N, Zahak A, et al. Antimicrobial sensitivity pattern of bacterial pathogens in urinary tract infections in South Delhi, India. Rev Recent Clin Trials. 2014; 9 :271-5.
CR  - 18. Choe HS, Lee SJ, Cho YH, et al.; GPIU Asian Investigators. Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU). J Infect Chemother 2018; 24 :278-83.
CR  - 19. Naz H, Cevik FC, Aykın N. Hastane kökenli üriner sistem infeksiyonları ve antibiyotik direnç profili. Dicle Med J 2009; 36: 85-90.
CR  - 20. Fasugba O, Gardner A, Mitchell BG, et al. Ciprofloxacin resistance in community-and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analtsis of observational studies.BMC Infectious Diseases 2015; 15: 545-60.
CR  - 21. Frei CR, Labreche MJ, Attridge RT. Fluoroguinolones in community-acguired pneumonia: guide to selection and appropiate use. Drugs 2011; 71: 757-70.
CR  - 22. Cıkman A, Gundem NS, Gulhan B, et al. İdrar kültürlerinden soyutlanan Enterobacteriaceae türlerinin GSBL üretimi ile ertapenem ve diğer antibiyotiklere direncinin belirlenmesi. Dicle Med J. 2014; 41 :474-8.
CR  - 23. Ijaz M, Khan SM, Hassan M, Bangash IH. Urinary tract infection in diabetic patients; causative bacteria and antibiotic sensitivity J. Med. Sci. 2014; 22 :110-4.
CR  - 24. Erden S, Çalangu S. Poliklinik hastalarında üriner sistem infeksiyonlarından izole edilen Escherichia coli suşlarının çeşitli antibiyotiklere in vitro duyarlılıkları. İstanbul Tıp Fakültesi Mecmuası 2002; 65: 147-9.
CR  - 25. Redgrave LS, Sutton SB, Webber MA, Piddock LJ. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role inevolutionary success. Trends Microbiol. 2014; 22 :438-45.
CR  - 26. Kim ES, Hooper DC.Clinical importance and epidemiology of quinolone resistance. Infect Chemother. 2014; 46: 641-6.
CR  - 27. Aral M, Kireçci E, Doğan SŞ. İdrar örneklerinden izole edilen gram negatif bakteriler ve antibiyotiklere direnç oranlarının retrospektif olarak değerlendirilmesi. Türk Mikrobiyoloji Cemiyeti Derg 2011; 41: 139-42.
CR  - 28. Gangcuangco LM, Alejandria M, Henson KE, et al. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country. Int J Infect Dis 2015; 34: 55-60.
CR  - 29. Vinken JEM, Mol HE, Verheij TJM, et al. Antimicrobial resistance in women with urinary tract infection in primary care: No relation with type 2 diabetes mellitus. Prim Care Diabetes. 2018; 12 :80-6.
CR  - 30. Yismaw G, Asrat D, Woldemanuel Y, et al. Urinary tract ınfection: Bacterial etiologies, drug resistance profile and associated risk factors in diabetic patients attending Gondar University Hospital, Gondar, Ethiopia. European Journal of Experimental Biology 2012; 2: 889-98.
UR  - https://doi.org/10.5798/dicletip.474694
L1  - https://dergipark.org.tr/en/download/article-file/560865
ER  -